Abstract:Abstract FDA anticipates that immune cell receptor profiling will become crucial to the Agency’s evaluation of the efficacy and safety of emerging cancer immunotherapies and immunomodulatory drugs by advancing precision medicine and providing orthogonal, functional evidence. High-throughput sequencing of B-cell receptor sequencing (BCR) gene rearrangements and downstream analysis empowers researchers to define the B-cell clonal landscape, as well as identify biomarkers for minimal residual disease (MRD). Although this field has made vast strides over the last decade, it lacks standardized assay controls, adequate sensitivity and specificity in gene mapping/alignment, and appropriately qualified reference data sets, materials, and validation methods. Moreover, detailed comparisons of wet-bench analytical methods or bioinformatic procedures have not appeared. The FDA led B-cell receptor sequencing quality control (BCR-SEQC) consortium is establishing protocols for the development of reference materials and data sets for the evaluation of NGS-based BCR repertoire reconstruction. The consortium is also developing materials for performance bench-marking studies. To this end, we performed whole-genome sequencing, RNAseq, and BCR-seq on 50 B-cell lines to determine the clonotype, full-length transcripts, and expression abundance of BCR genes in each cell line. Two batches of reference materials (DNA, RNA, and cells) were generated from each of nine cell lines that were determined unambiguously to be monoclonal in BCR expression of both heavy and light chains. These materials were distributed to ten companies to test up to 15 BCR-seq products. Our benchmarking studies include six widely-used sequencing technologies. The overarching objectives of this research were to elucidate current capabilities and limitations, address fundamental technical needs, provide reference materials and data sets, and establish actionable best practices for reconstructing B cell receptor repertoires from NGS data. Citation Format: Wenming Xiao, BCR-SEQC consortium. Toward best practices for B-cell receptor repertoire profiling [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 80.

AAB-seq: An antigen-specific and affinity-readable high-throughput BCR sequencing method

Using B cell receptor lineage structures to predict affinity

A rapid novel strategy for screening of antibody phage libraries for production, purification, and functional characterization of amber stop codons containing single‐chain antibody fragments

A recycling model of the biokinetics of systemic tellurium

Abstract 80: Toward best practices for B-cell receptor repertoire profiling

Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cells

Current advancements in B-cell receptor sequencing fast-track the development of synthetic antibodies

A high throughput bispecific antibody discovery pipeline

Benchmarking and integrating human B-cell receptor genomic and antibody proteomic profiling

Cmai: Predicting Antigen-Antibody Interactions from Massive Sequencing Data

Single-domain antibody screening by is PLA-seq

What the Body Knows.

High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics

Microfluidic-assisted single-cell RNA sequencing facilitates the development of neutralizing monoclonal antibodies against SARS-CoV-2

Measuring the sequence-affinity landscape of antibodies with massively parallel titration curves

FB5P-seq-mAbs: monoclonal antibody production from FB5P-seq libraries for integrative single-cell analysis of B cells

High-throughput antibody screening with high-quality factor nanophotonics and bioprinting

Computational detection of antigen specific B cell receptors following immunization

Antibody Binding Epitope Mapping (AbMap) of Hundred Antibodies in a Single Run

Generation and Screening of Antigen-Specific Nanobodies from Mammalian Cells Expressing the BCR Repertoire Library Using Droplet-Based Microfluidics

AttABseq: an Attention-Based Deep Learning Prediction Method for Antigen-Antibody Binding Affinity Changes Based on Protein Sequences.